Tecnoquimicas S.A, founded in 1957 by the merger of Colombian Sales Company and Laboratorios Fixalia is a company dedicated to producing and commercialization of products and services in the areas of health, personal care and cleanliness of the home, processed foods and agricultural and veterinary products. In 1993 acquired the companies Organizacion Farmeceutica Colombiana S.A. and Distribuidora Farmaceutica Calox Colombia S.A. and with them an important group of national brands as Sal de Frutas Lua, Yodora and Blankisima. Also It acquired the brand MK in order to manufacture and market generic pharmaceutical products for human and veterinary use in Colombia, Peru, Ecuador and Bolivia. In 1996 started the production of Winny and Velty brands in Tecnosur, partnership between Colombiana Kimberly Colpapel and Tecnoquimicas. In 1999 it bought the brand Colbon. in 2000, acquired from Tootsie Roll Inc the franchise Charms. in July 2008, IFC became a partner in the company. Teramed, a company in the pharmaceutical sector in El Salvador, was acquired in 2009, initiating a strong presence in Central America.
Basic Information
Key Executives
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Company Performance
Financial values in the chart are available after Tecnoquimicas S.A. report is purchased.
Looking for more than just a company report?
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
30.34%▲
Total operating revenue
28.94%▲
Operating profit (EBIT)
26.17%▲
Net Profit (Loss) for the Period
22.01%▲
Operating Profit Margin (ROS)
-0.28%▼
Net Profit Margin
-1.09%▼
Return on Equity (ROE)
0.33%▲
Debt to Equity Ratio
5.42%▲